Native versus recombinant high-mobility group B1 proteins: Functional activity in vitro

Inflammation

Volumn 28, Issue 4, 2004, Pages 221-229

  Zimmermann, Klaus ^a   Völkel, Dirk ^a   Pable, Sabrina ^a   Lindner, Thomas ^a   Kramberger, Franziska ^a   Bahrami, Soheyl ^b   Scheiflinger, Friedrich ^a  

^a BAXTER BIOSCIENCE   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

HMGB1; Inflammation; Proliferation; THP 1; TNF release

Indexed keywords

COMPLEMENTARY DNA; HIGH MOBILITY GROUP B1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; HYBRID PROTEIN; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CATTLE; CELL PROLIFERATION; CHO CELL; CONTROLLED STUDY; DRUG EFFICACY; EUKARYOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PROKARYOTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYMUS; AMINO ACID SEQUENCE; ANIMAL; CELL STRAIN 3T3; COMPARATIVE STUDY; DRUG ANTAGONISM; GENE VECTOR; GENETICS; HAMSTER; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PHYSIOLOGY; SECRETION; TUMOR CELL LINE;

ANIMALIA; BOS TAURUS; CRICETULUS GRISEUS; EUKARYOTA; MURINAE; PROKARYOTA;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHO CELLS; CRICETINAE; GENETIC VECTORS; HMGB1 PROTEIN; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PYRUVATES; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18444362106     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:IFLA.0000049047.61014.e3     Document Type: Article

References (33)

1. Goodwin, G. H. and E. W. Johns. 1977. The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins. Methods Cell Biol. 16:257-267.
2. Bianchi, M. E. 1994. Prokaryotic HU and eukaryotic HMG1: A kinked relationship. Mol. Microbiol. 14:1-5.
3. Bianchi, M. E. and M. Beltrame. 2000. Upwardly mobile proteins. The role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep. 1:109-119.
4. Bustin, M. 2001. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem. Sci. 26:152-153.
5. Bustin, M. 1999. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell Biol. 19:5237-5246.
6. Yang, H., H. Wang, and K. J. Tracey. 2001. HMG-1 rediscovered as a cytokine. Shock 15:247-253.
7. Ura, K., K. Nightingale, and A. P. Wolffe. 1996. Differential association of HMG1 and linker histones B4 and H1 with dinucleosomal DNA: Structural transitions and transcriptional repression. EMBO J. 15:4959-4969.
8. Falciola, L., F. Spada, S. Calogero, G. Längst, R. Voit, I. Grummt, and M. E. Bianchi. 1997. High mobility group 1 (HMG1) protein is not stably associated with the chromosomes of somatic cells. J. Cell Biol. 137:19-26.
9. Czura, C. J., H. Wang, and K. J. Tracey. 2001. Dual roles for HMGB1: DNA binding and cytokine. J. Endotoxin Res. 7:315-321.
10. Merenmies, J., R. Pihlaskari, J. Laitinen, J. Wartiovaara, and H. Rauvala. 1991. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth: Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J. Biol. Chem. 266:16722-16729.
11. Fages, C., R. Nolo, H. J. Huttunen, E. Eskelinen, and H. Rauvala. 2000. Regulation of cell migration by amphoterin. J. Cell. Sci. 113:611-620.
12. Parkkinen, J. and H. Rauvala. 1991. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J. Biol. Chem. 266:16730-16735.
13. Ayer, L. M., J. L. Senecal, L. Martin, G. H. Dixon, and M. J. Fritzler. 1994. Antibodies to high mobility group proteins in systemic sclerosis. J. Rheumatol. 21:2071-2075.
14. Rosenberg, A. M. and D. M. Cordeiro. 2000. Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis. J. Rheumatol. 27:2489-2493.
15. Sobajima, J., S. Ozaki, H. Uesugi, F. Osakada, M. Inoue, Y. Fukuda, H. Shirakawa, M. Yoshida, A. Rokuhara, H. Imai, K. Kiyosawa, and K. Nakao. 1999. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 44:867-873.
16. Sparatore, B., M. Passalacqua, M. Patrone, E. Melloni, and S. Pontremoli. 1996. Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. Biochem. J. 320:253-256.
17. Kallijarvi, J., M. Haltia, and M. H. Baumann. 2001. Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. Biochemistry 40:10032-10037.
18. Yamamura, J., Y. Takada, M. Goto, M. Kumegawa, and S. Aoe. 1999. High mobility group-like protein in bovine milk stimulates the proliferation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 261:113-137.
19. Sappington, P. L., R. Yang, H. Yang, K. J. Tracey, R. L. Delude, and M. P. Fink. 2002. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123:790-802.
20. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K. R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P. E. Molina, N. N. Abumrad, A. Sama, and K. J. Tracey. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251.
21. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165:2950-2954.
22. Wang, H., J. M. Vishnubhakat, O. Bloom, M. Zhang, M. Ombrellino, A. Sama, and K. J. Tracey. 1999. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126:389-392.
23. Fang, W. H., Y. M. Yao, Z. G. Shi, Y. Yu, Y. Wu, L. R. Lu, and Z. Y. Sheng. 2002. The significance of changes in high mobility group-1 protein mrna expression in rats after thermal injury. Shock 17:329-333.
24. Scaffidi, P., T. Misteli, M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195.
25. Goodwin, G. H., C. Sanders, and E. W. Johns. 1973. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 38:14-19.
26. Adachi, Y., S. Mizuno, and M. Yoshida. 1990. Efficient large-scale purification of non-histone chromosomal proteins HMG1 and HMG2 by using Polybuffer-exchanger PBE94. J. Chromatogr. 530:39-46.
27. Urlaub, G., L. A. Chasin. 1980. Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci. U S A. 77:4216-4220.
28. Graf, L. H. Jr, and L. A. Chasin. 1982. Direct demonstration of genetic alterations at the dihydrofolate reductase locus after gamma irradiation. Mol. Cell. Biol. 2:93-96.
29. Ulloa, L., M. Ochani, H. Yang, M. Tanovic, D. Halperin, R. Yang, C. J. Czura, M. P. Fink, and K. J. Tracey. 2002. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. U S A. 99:12351-12356.
30. Venkataraman, R., J. A. Kellum, M. Song, and M. P. Fink. 2002. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 18:507-512.
31. Tawadrous, Z. S., R. L. Delude, and M. P. Fink. 2002. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17:473-477.
32. Taguchi, A., D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y Lu, E. Lalla, C. Fu, M. A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D. M. Stern, and A. M. Schmidt. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354-360.
33. Andrei, C., C. Dazzi, L. Lotti, M. R. Torrisi, G. Chimini, and A. Rubartelli. 1999. The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell. 10:1463-1475.